<div id="readability-page-1">Bioventix PLC (LON:BVXP - Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 1,600 and last traded at GBX 1,650, with a volume of 9292 shares traded. The stock had previously closed at GBX 1,700.<h2>Bioventix Stock Performance</h2><p>The firm has a fifty day moving average price of GBX 1,790.42 and a 200 day moving average price of GBX 2,115.63. The firm has a market capitalization of £86.21 million, a price-to-earnings ratio of 11.52 and a beta of 0.35.</p><h2>Insider Buying and Selling</h2><p>In related news, insider Bruce Hiscock purchased 150 shares of the stock in a transaction dated Tuesday, November 25th. The shares were acquired at an average cost of GBX 2,071 per share, with a total value of £3,106.50. Company insiders own  6.16% of the company's stock. </p><h2>Bioventix Company Profile</h2> (Get Free Report)<p>Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. </p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Bioventix</li><li>Your Bank Account Is No Longer Safe</li><li>Nvidia CEO Issues Bold Tesla Call</li><li>Buy this Gold Stock Before May 2026</li><li>What a Former CIA Agent Knows About the Coming Collapse</li><li>This $15 Stock Could Go Down as the #1 Stock of 2026</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Bioventix Right Now?</h2><p>Before you consider Bioventix, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.</p><p>While Bioventix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Bioventix PLC (LON:BVXP) reached a new 52-week low of GBX 1,600 during trading, closing at GBX 1,650. The stock has a market cap of £86.21 million and a P/E ratio of 11.52. Insider Bruce Hiscock bought 150 shares at GBX 2,071. Bioventix specializes in sheep monoclonal antibodies for diagnostics and has a Hold rating from analysts, who suggest better investment options are available.</p>

Bioventix (LON:BVXP) Sets New 1-Year Low - Here's What Happened